NCVI Enterprises Limited, a promoter group entity, bought 7,00,000 shares of IOL Chemicals and Pharmaceuticals Limited for ₹4.82 crore at ₹68.89 apiece in a market purchase, increasing its stake from 15.96% to 16.20%.
A leading pharmaceutical company, IOL Chemicals manufactures active pharmaceutical ingredients and specialty chemicals for both domestic and international markets. The company serves pharmaceutical manufacturers, agrochemical producers, and other industrial clients across multiple sectors. Its integrated operations span chemical synthesis, process development, quality assurance, and regulatory compliance. IOL Chemicals maintains manufacturing facilities equipped with advanced technology to ensure product quality and consistency across its diverse portfolio.
